Protein/peptide-based entry/fusion inhibitors as anti-HIV therapies: challenges and future direction.
Rev Med Virol. 2016 Jan;26(1):4-20. doi: 10.1002/rmv.1853. Epub 2015 Aug 26.
Rev Med Virol. 2016.
PMID: 26308574
Review.